PHO.OL Live signals | Maximize Profits with Getagraph.com

BUY 555 min ago

@ NOK54.00

Issued: 19 Apr 2024 @ 07:56

Return: 1.48%

Previous signal: Apr 19 - 05:28

Previous signal: Sell

Return: 1.69 %

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 10:25):
Our systems believe the stock currently is undervalued by 0.56% compare to its pairs and should correct upwards.

Stats
Today's Volume	39 437.00
Average Volume	81 892.00
Market Cap	1.49B
EPS	NOK0 ( 2024-02-20 )
Next earnings date	( NOK-0.300 ) 2024-05-15
Last Dividend	NOK2.00 ( 2013-05-23 )
Next Dividend	NOK0 ( N/A )
P/E	-44.19
ATR14	NOK1.600 (2.98%)

Correlation (AI algo v.1.1b): Undervalued: 0.56% NOK54.00 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: 0.31 (neutral)

Short: 0.00 (neutral)

Signal:(4) Neutral

Photocure ASA Correlation

10 Most Positive Correlations
AKH.OL	0.929
NAPA.OL	0.913
VOLUE.OL	0.91
ELABS.OL	0.896
NRC.OL	0.895
TRVX.OL	0.881
ENTRA.OL	0.88
EFUEL.OL	0.878
XXL.OL	0.876
AKRBP.OL	0.875

10 Most Negative Correlations
NAVA.OL	-0.921
ENDUR.OL	-0.888
NORSE.OL	-0.874
NTEL.OL	-0.871
ASTK.OL	-0.867
BWLPG.OL	-0.866
SNI.OL	-0.864
SMOP.OL	-0.861
AYFIE.OL	-0.86
BORR.OL	-0.842

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Photocure ASA Correlation - Currency/Commodity

-0.16
( neutral )

-0.01
( neutral )

0.00
( neutral )

-0.05
( neutral )

-0.78
( moderate negative )

-0.21
( neutral )

Photocure ASA Financials

Annual	2023
Revenue:	NOK500.66M
Gross Profit:	NOK446.83M (89.25 %)
EPS:	NOK0.00990

Q4	2023
Revenue:	NOK142.55M
Gross Profit:	NOK129.22M (90.65 %)
EPS:	NOK0.460

Q3	2023
Revenue:	NOK107.55M
Gross Profit:	NOK100.65M (93.59 %)
EPS:	NOK-0.180

Q2	2023
Revenue:	NOK144.32M
Gross Profit:	NOK137.44M (95.23 %)
EPS:	NOK0.160

Financial Reports:

No articles found.

Photocure ASA Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
NOK0 (N/A)	NOK0 (N/A)	NOK0 (N/A)	NOK0 (N/A)	NOK0 (N/A)	NOK0 (N/A)	NOK0 (N/A)	NOK0 (N/A)	NOK0 (N/A)	NOK0 (N/A)

Photocure ASA Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 8.50 - good (84.99%) | Divividend Growth Potential Score: 2.81 - No dividend growth expected in the near future

Information

First Dividend	NOK4.00	2009-11-26
Last Dividend	NOK2.00	2013-05-23
Next Dividend	NOK0	N/A
Payout Date	2013-06-11
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	NOK6.00	--
Avg. Dividend % Per Year	0.00%	--
Score	1.92	--
Div. Sustainability Score	8.50
Div.Growth Potential Score	2.81
Div. Directional Score	5.65	--

Next Divdend (Est)
(2027-03-31)

NOK0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

1.92

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield
2009	NOK4.00	18.30%
2010	NOK0	0.00%
2011	NOK0	0.00%
2012	NOK0	0.00%
2013	NOK2.00	5.14%
2014	NOK0	0.00%
2015	NOK0	0.00%
2016	NOK0	0.00%
2017	NOK0	0.00%
2018	NOK0	0.00%
2019	NOK0	0.00%
2020	NOK0	0.00%
2021	NOK0	0.00%
2022	NOK0	0.00%
2023	NOK0	0.00%
2024	NOK0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for OSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
ALNG.OL	Dividend King	2023-11-27	Quarterly	2	6.60%	7.04
OKEA.OL	Dividend Knight	2023-12-01	Quarterly	3	5.65%	6.86
SALM.OL	Dividend Knight	2023-06-09	Annually	17	2.80%	4.97
BWLPG.OL	Dividend Knight	2023-11-17	Quarterly	11	1.68%	4.46
ELK.OL	Dividend Knight	2023-05-02	Annually	6	6.64%	4.31
BWO.OL	Dividend Knight	2023-11-20	Quarterly	14	0.87%	3.96
ATEA.OL	Dividend Knight	2023-11-20	Annually	16	2.97%	3.45
HAFNI.OL	Dividend Knight	2023-11-23	Semi-Annually	5	1.18%	3.31
AKER.OL	Dividend Knight	2023-11-07	Semi-Annually	20	2.99%	3.13
AUSS.OL	Dividend Knight	2023-05-26	Annually	17	3.23%	2.93

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.000535	1.500	9.99	10.00	[0 - 0.5]
returnOnAssetsTTM	0.000377	1.200	9.99	10.00	[0 - 0.3]
returnOnEquityTTM	0.000572	1.500	-1.105	-1.657	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	4.80	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	4.32	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	3.35	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	1.535	1.000	-0.543	-0.543	[3 - 30]
operatingCashFlowPerShareTTM	1.949	2.00	9.35	10.00	[0 - 30]
freeCashFlowPerShareTTM	1.495	2.00	9.25	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.933	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.131	1.000	9.39	9.39	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0.704	0.800	8.64	6.91	[0.5 - 2]
Total Score				8.50

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	5 825.70	1.000	10.00	0	[1 - 100]
returnOnEquityTTM	0.000572	2.50	-0.710	-1.657	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.495	2.00	9.50	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	1.949	2.00	9.35	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-247.32	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.105	1.000	9.86	0	[0.1 - 0.5]
Total Score				2.81

Photocure ASA

Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the Netherlands, Italy, other European Countries, and the United States. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus infection and precancerous lesions of the cervix. The company sells its products to pharmaceutical wholesalers, pharmacies, and hospitals through license partners. Photocure ASA was founded in 1993 and is headquartered in Oslo, Norway.